POST EVENT REPORT

11 - 12 March 2026 | Marina Bay Sands Expo and Convention Center, Singapore

Attendees

Companies

Speakers

MESSAGE FROM THE ORGANISER

ADC Asia Congress 2026 welcomed 91 attendees, 25 expert speakers, and 51 attending organisations, bringing together professionals working across the antibody–drug conjugate (ADC) development landscape in the Asia-Pacific region.

The programme explored key topics shaping the rapidly evolving ADC field, including next-generation conjugation technologies, linker and payload innovation, CMC strategies, clinical development pathways, and manufacturing considerations for ADC therapeutics. Discussions also addressed the growing role of Asia as a hub for ADC research and development, highlighting opportunities for collaboration between regional biopharma companies, global pharmaceutical organisations, and specialised technology providers.

Attendees included representatives from pharmaceutical and biopharma companies, biotechnology firms, CDMOs, CROs, and technology providers, with sessions focused on overcoming development challenges such as complex manufacturing processes, safety considerations, and the optimisation of ADC design to improve therapeutic outcomes.

With organisations represented from Singapore, China, Japan, South Korea, Australia, and across the wider Asia-Pacific region, ADC Asia Congress continues to provide a platform for knowledge exchange and collaboration across the region’s expanding ADC ecosystem.

Sincerely, IMAPAC

Attendee Breakdown

By Country

By Job Title

By Industry

Testimonials

“Good team, clever techniques to bring people in contact. Appreciate their effort and help.”

Product & Sales Manager, DrM Group, Switzerland

“Great experience! Nice speakers and exhibitions!”

CEO, HoneyBear Biosciences, Inc., Taiwan

“Friendly partnership, staff are very helpful.”

R&D Director, HyQure Biotech, China

“Good selection of topics and speakers.”

Senior Scientist, Bioprocessing Technology Institute, A*STAR

“Imapac always manages to invite some very inspiring speakers.”

Director, Asset Lead, EDDC

“The team was very friendly and helpful. They were committed to scheduling 1-to-1 meetings and ensuring it went smoothly.”

BDM, SGS

“Overall, we believe the event was very well organized and successful. From an exhibitor’s perspective, the arrangement of 1-to-1 meetings was particularly useful and added significant value.”

Business Development Director, Pfanstiehl

“Thank you so much for organizing such a well-run event. It was truly a pleasure to contribute, and I enjoyed the atmosphere and engagement from the audience during the event.”

Corporate Performance Specialist, Biofarma

“Thanks for organizing BioSupply Chain Asia, it was a good event and I have learnt a lot.”

Head of Singapore Expore Platform, Sanofi, Singapore

“It was a very valuable conference experience. I was pleased to have the opportunity to present and discuss our technology with peers in the field, which led to several new and meaningful engagements. The meeting also offered a strong scientific programme, and it was inspiring to hear high-quality work from other groups. Beyond the content itself, the conference was especially useful for building new connections and opening the door to potential future collaborations.”

CTO, Singzyme, Singapore

"It was a fantastic experience speaking at the 2nd ADC Asia Congress. The event showcased cutting-edge advancements in the field and provided a valuable platform for meaningful discussions with key industry leaders. I look forward to seeing how this community continues to grow."

Dr. Nan Yu, Senior Director and ADC MedChem Group Head, Innovent Biologics, China

“The ADC Asia Congress provided an excellent platform for meaningful exchange across the biomanufacturing community in the Asia-Pacific region. The strong emphasis on translating upstream innovation into manufacturing impact was particularly valuable, aligning closely with the evolving needs of lifecycle-ready biologics development.”

Takashi Kaminagayoshi, Head of Biotherapeutics Process Development Japan, Pharmaceutical Sciences, Takeda, Japan

"Insights from industry leaders are valuable and cannot be found easily online"

Technical Steward, BioNTech, Singapore

This 2nd ADC Asia Congress was well organized with lots of excellent speakers and informative materials. Well organized to ensure everyone in the ADC field to get to know the state of art in this fast growing field.